Loading...

Murray Stein

Title(s)Distinguished Professor, Psychiatry, Psychiatry
SchoolHealth Sciences
Phone858-534-6451
ORCID ORCID Icon0000-0001-9564-2871 Additional info
vCardDownload vCard
    Other Positions
    Title(s)Distinguished Professor, Family Medicine and Public Health


    Collapse Overview 
    Collapse Overview
    Biography

    Murray B Stein MD, MPH, FRCPC is Distinguished Professor of Psychiatry and Family Medicine & Public Health, and Vice Chair for Clinical Research in Psychiatry at the University of California San Diego (UCSD). He is also a Staff Psychiatrist at the VA San Diego Healthcare System. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, MD.

    Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 600 peer-reviewed scientific articles on these topics, including in journals such as JAMA, New England Journal of Medicine, The Lancet, American Journal of Psychiatry, and JAMA Psychiatry. His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2015) investigating risk factors for suicide, PTSD and other deployment-related disorders; this project is now in a longitudinal follow-up phase as STARRS-LS (2015-2019). He is Co-Principal Investigator with Kerry Ressler MD PhD of a DoD-funded multi-site trial of losartan for PTSD (2015-2019). He is also Co-Principal Proponent (with Joel Gelernter MD) of a VA Cooperative Genomewide Association Study of PTSD (2013-2018), in conjunction with the VA Million Veteran Program.

    Dr. Stein is a member of the Scientific Advisory Board of the Anxiety and Depression Association of American (ADAA), and a Fellow of the American College of Neuropsychopharmacology (ACNP). Dr. Stein is a past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009), and was a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-2013). He is a past member of the National Academy of Medicine Board on the Health of Select Populations (2012-2015) and the National Academy of Medicine Committee to Review NASA's Evidence Reports on Human Health Risks (2016). He is a past member of the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) (2011-2016). Dr. Stein sits on the Scientific and Ethical Oversight Committee for the Vietnam Era Twin Study.

    Dr. Stein is Co-Editor-in-Chief for UpToDate in Psychiatry, Editor-in-Chief for the journal Depression and Anxiety, and Deputy Editor for the journal Biological Psychiatry.

    Collapse Research 
    Collapse Research Activities and Funding
    Genomics of PTSD and Related Traits
    VA I01CX001849Jul 1, 2019 - Jun 30, 2023
    Role: Co-Principal Investigator
    Psychiatric Genomics Consortium for PTSD
    NIH/NIMH R01MH106595Aug 19, 2016 - Jun 30, 2024
    Role: Co-Principal Investigator
    A GEWIS Study of Smoking, Hazardous Drinking, and Other Health Risk Behaviors
    NIH/NIAAA R21AA024404Apr 1, 2015 - Mar 31, 2017
    Role: Co-Principal Investigator
    Modifiable Risk and Protective Factors for Suicidal Behaviors in the US Army
    NIH/NIMH U01MH087981Jul 16, 2009 - Sep 29, 2012
    Role: Co-Principal Investigator
    Pharmacological fMRI to Identify New Anxiolytics: A Human Bioassay
    NIH/NIMH R01MH075792Jul 20, 2006 - Jun 30, 2010
    Role: Principal Investigator
    Improving Outcomes in Pharmacotherapy of Social Phobia
    NIH/NIMH R01MH070501Sep 28, 2005 - Jul 31, 2011
    Role: Principal Investigator
    Neural Substrates of Anticipation and Interoception in Anxiety Disorders
    NIH/NIMH R01MH065413Apr 1, 2002 - May 31, 2013
    Role: Principal Investigator
    Improving Outcomes and Understanding Response Heterogeneity in Anxiety Disorders
    NIH/NIMH K24MH064122Jul 27, 2001 - May 31, 2013
    Role: Principal Investigator
    Preventing Psychiatric Sequelae of Traumatic Injury
    NIH/NIMH R21MH062037May 4, 2001 - Apr 30, 2005
    Role: Principal Investigator
    CALM: Improving Primary Care Anxiety Outcomes
    NIH/NIMH U01MH057835Sep 21, 1999 - May 31, 2012
    Role: Principal Investigator
    IMPROVING CARE FOR PANIC DISORDER IN PRIMARY CARE
    NIH/NIMH R01MH057835Jul 1, 1999 - Jun 30, 2004
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites